Brian Shuch, MD, of UCLA Health, previews his upcoming sessions at Urology on the Beach 2025, taking place January 17, 2025, to January 19, 2025, at the Fontainebleau Miami Beach. This comprehensive event covers all aspects of urology with presentations from leading experts in the field. Dr. Shuch’s presentation will cover the use of molecular imaging agents and their role in risk stratification and informed treatment decisions.
Urology on the Beach 2025 Preview: New Trends in RCC Care and Imaging
By Brian Shuch, MD - Last Updated: January 9, 2025Related Posts
A recent proof-of-concept study has further evaluated the efficacy of PSMA-guided MDT for oligometastatic RCC.
Dr. Dan Joyce discusses key SUO studies on RCC prognostics, personalized medicine, and advancements in treatment strategies.
Dr. Karam explains the main points of emphasis when it comes to small renal masses and surveillance versus surgery.
Serial ctDNA negativity or clearance was linked to improved PFS compared with persistent ctDNA positivity during treatment.
The phase 3 ZIRCON trial demonstrated positive results with use of the agent for patients with ccRCC.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.